| 1. | | Recruiting | Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
Conditions: Leukemia, Lymphocytic, Chronic; Leukemia, Lymphocytic, Acute; Lymphoma, Low-Grade; Lymphoma, T-Cell; Lymphoma, B-Cell |
| 2. | | Not yet recruiting | Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ... |
| 3. | | Recruiting | Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Conditions: Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ... |
| 4. | | Recruiting | Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ... |
| 5. | | Recruiting | Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ... |
| 6. | | Recruiting | Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
Conditions: untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ... |
| 7. | | Recruiting | LMB-2 Immunotoxin in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ... |
| 8. | | Recruiting | Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
Conditions: B-cell adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ... |
| 9. | | Recruiting | Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Conditions: stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; ... |
| 10. | | Recruiting | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 11. | | Recruiting | Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 12. | | Recruiting | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
Conditions: stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ... |
| 13. | | Recruiting | Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ... |
| 14. | | Recruiting | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia |
| 15. | | Recruiting | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Conditions: L3 adult acute lymphoblastic leukemia; adult Burkitt's lymphoma; untreated adult acute lymphoblastic leukemia |
| 16. | | Recruiting | Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Conditions: L3 adult acute lymphoblastic leukemia; adult Burkitt's lymphoma; untreated adult acute lymphoblastic leukemia |
| 17. | | Recruiting | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
Conditions: acute undifferentiated leukemia; childhood acute lymphoblastic leukemia; childhood lymphoblastic lymphoma |
| 18. | | Recruiting | Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)
Condition: Leukemia, Lymphocytic, Chronic |
| 19. | | Recruiting | Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; stage I cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ... |
| 20. | | Recruiting | Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
Conditions: stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia |
| 21. | | Recruiting | Phase 1 Study of BL22 to Treat Acute Lymphocytic Leukemia or Non-Hodgkin's Lymphoma in Children and Young Adults
Conditions: Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Acute |
| 22. | | Recruiting | Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia |
| 23. | | Recruiting | Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia |
| 24. | | Recruiting | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Conditions: Anemia; Chronic Lymphocytic Leukemia; Neutropenia; Thrombocytopenia |
| 25. | | Recruiting | Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 26. | | Recruiting | FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia
Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ... |
| 27. | | Recruiting | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Conditions: Philadelphia chromosome positive chronic myelogenous leukemia; adult acute lymphoblastic leukemia; adult lymphoblastic lymphoma; ... |
| 28. | | Recruiting | Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia |
| 29. | | Recruiting | Megadose CD34 Selected Progenitor Cells for Transplantation in Patients with Advanced Hematological Malignant Diseases
Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome; Chronic Lymphocytic Leukemia; Non Hodgkin's Lymphoma |
| 30. | | Recruiting | Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia; ... |
| 31. | | Recruiting | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia |
| 32. | | Recruiting | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Children With Acute Lymphoblastic Leukemia
Conditions: recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission |
| 33. | | Recruiting | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
Conditions: childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia |
| 34. | | Recruiting | Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission |
| 35. | | Recruiting | CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 36. | | Recruiting | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 37. | | Recruiting | Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 38. | | Recruiting | Monoclonal Antibody Therapy in Treating Patients With Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Conditions: AIDS-related peripheral and systemic lymphoma; adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; ... |
| 39. | | Recruiting | Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 40. | | Recruiting | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; Prolymphocytic Leukemia; ... |
| 41. | | Recruiting | OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 42. | | Not yet recruiting | FR901228 and Rituximab in Treating Patients With Previously Treated B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia |
| 43. | | Recruiting | Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia |
| 44. | | Recruiting | Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia |
| 45. | | Recruiting | Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; recurrent adult acute lymphoblastic leukemia; ... |
| 46. | | Not yet recruiting | Pentostatin, Cyclophosphamide, and Rituximab Followed By Alemtuzumab in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia |
| 47. | | Recruiting | 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma |
| 48. | | Recruiting | Phase II Study of Hyper-CVAD plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
Condition: Leukemia, Lymphocytic, Acute, L2 |
| 49. | | Recruiting | HuMax-CD20 in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia |
| 50. | | Not yet recruiting | FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma |
